REFERENCE
Zilberberg MD, Mody SH, Chen J, Evangelista AT, Shorr AF.Cost-benefit model of empiric doripenem compared to imipenem in ventilator-associated pneumonia. 2008 Annual Meeting of the American College of Chest Physicians: abstr. P49003, 28 Oct 2008. Available from: URL: http://meeting.chestjournal.org
Rights and permissions
About this article
Cite this article
Empiric doripenem in VAP may dominate imipenem. Pharmacoecon. Outcomes News 568, 5 (2008). https://doi.org/10.2165/00151234-200805680-00011
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805680-00011